RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 15 - per page Next page
Order by
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
5 and 10 mg Donepezil are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Opioid receptor blocker which reduces desire for opioids and alcohol, use in psychiatry, neurology and addition medicine. More
Kappa opioid receptor agonist/ mü antagonist providing analgesia, while preventing respiratory depression More
Opioid receptor antagonist reducing opioid induced respiratory depression More
Treatment of movement disorders associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea. More
Ultrashort acting beta blocker Esmolol for use in anesthesia, intensive care, cardiology and internal medicine. More
Displaying 1..10 of 15 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Sep 2011 - 39 pages - $250
Sep 2010 - 37 pages - $250
Oct 2010 - 112 pages - $7,600
Sep 2011 - 40 pages - $250
Sep 2011 - 42 pages - $250
Sep 2010 - 38 pages - $250
Sep 2010 - 37 pages - $250
Sep 2011 - 43 pages - $250

Your selection

Industry sector
Pharmaceutical del
Generics del
Development phase
Preclinical del

Visit also genericlicensing.com

The website which helps the generic industry do business. Visit now

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us